Tanya Coleman
GlaxoSmithKline
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Tanya Coleman.
Bioorganic & Medicinal Chemistry Letters | 2008
Susan Marie Westaway; Mervyn Thompson; Harshad Kantilal Rami; Geoffrey Stemp; Leontine S. Trouw; Darren Jason Mitchell; Jon T. Seal; Stephen J. Medhurst; Sarah C. Lappin; James Biggs; James Wright; Sandra Arpino; Jeffrey C. Jerman; Jennifer E. Cryan; Vicky Holland; Kim Winborn; Tanya Coleman; Alexander J. Stevens; John B. Davis; Martin J. Gunthorpe
6-Phenylnicotinamide (2) was previously identified as a potent TRPV1 antagonist with activity in an in vivo model of inflammatory pain. Optimization of this lead through modification of both the biaryl and heteroaryl components has resulted in the discovery of 6-(4-fluorophenyl)-2-methyl-N-(2-methylbenzothiazol-5-yl)nicotinamide (32; SB-782443) which possesses an excellent overall profile and has been progressed into pre-clinical development.
Bioorganic & Medicinal Chemistry Letters | 2003
Ian Thomson Forbes; David G. Cooper; Emma K. Dodds; Sara E. Douglas; Andrew Derrick GlaxoSmithKline Gribble; Robert J. Ife; Andrew P. Lightfoot; Malcolm Meeson; Lorraine Campbell; Tanya Coleman; Graham J. Riley; David R. Thomas
Novel 5-HT(7) receptor antagonists containing the benzocycloheptanone core were identified from high throughput screening. Molecular modelling and SAR studies have converted these intractable hits into a more potent, selective and tractable series, exemplified by compound (25), SB-691673.
Journal of agricultural safety and health | 1999
D. Rh. Thomas; R. L. Salmon; Tanya Coleman; P. Morgan-Capner; M. Sillis; E.O. Caul; K. L. Morgan; G. A. Paiba; M. Bennett; D. Ribeiro; G. Lloyd; S. M. Kench; D. Meadows; P. Softley; Rachel M. Chalmers
We recruited a representative population-based sample of 606 farmers, farmworkers, and their families from three areas of England. By defining and measuring animal exposure (type, frequency, and species range) we were able not only to measure the incidence and prevalence of markers of exposure to zoonotic organisms in this sentinel group, but also to determine the risk of exposure to zoonotic organisms associated with a variety of defined occupational exposures. Prevalence of antibodies to Coxiella burnetii (the cause of Q fever) (29.2%) and toxoplasma (50.2%) were high; whereas, prevalence of antibodies to Borrelia burgdorferi (the cause of Lyme disease) (0.2%), leptospira (0.2%), and brucella (0.7%) were low. The cohort was also exposed to hantavirus (seroprevalence 4.7%), orthopoxvirus (0.7%), parapoxvirus (4.5%), Bartonella spp. (2.0%) Ehrlichia chaffeensis (0.2%), human granulocytic ehrlichiosis agent (1.5%), and Echinococcus granulosis 3/202 (1.5%). Coxiella seropositivity was associated with exposure to dairy cattle (odds ratio: 1.48, 95% confidence interval: 1.03-2.12); cowpox with exposure to rats (odds ratio: 18.7, 95% confidence interval: 1.7-201.8). Self-reported clinical orf (contagious pustular dermatitis) was associated with exposure to sheep (risk ratio: 7.64, 95% confidence interval: 1.93-30.26) and rats (risk ratio 4.54, 95% confidence interval: 1.16-17.70); ringworm (dermatophytosis) with cattle (risk ratio: 1.76; 95% confidence interval: 1.17-2.64).
Archive | 1996
D. Rh. Thomas; R. L. Salmon; D. Meadows; P. Morgan-Capner; S. M. Kench; Tanya Coleman
Although Helicobacter pylori is probably the most common human pathogen worldwide, it’s epidemiology is largely unknown. To determine it’s occupational significance, if any, and mode of transmission, we measured the prevalence and incidence of IgG specific antibody to H.pylori in a representative cohort of farmworkers and collected detailed exposure data.
Bioorganic & Medicinal Chemistry Letters | 2006
Adrian Hall; Stephen John Atkinson; Susan H. Brown; Iain P. Chessell; Anita Chowdhury; Nicholas Maughan Clayton; Tanya Coleman; Gerard Martin Paul Giblin; Robert J. Gleave; Beverley Hammond; Mark P. Healy; Matthew R. Johnson; Anton D. Michel; Alan Naylor; Riccardo Novelli; David J. Spalding; Sac P. Tang
Bioorganic & Medicinal Chemistry Letters | 2006
Stephen C. McKeown; Adrian Hall; Gerard Martin Paul Giblin; Olivier Lorthioir; Richard Blunt; Xiao Qing Lewell; Richard J. Wilson; Susan H. Brown; Anita Chowdhury; Tanya Coleman; Stephen P. Watson; Iain P. Chessell; Adrian Pipe; Nick M. Clayton; Paul Goldsmith
Bioorganic & Medicinal Chemistry Letters | 2006
Adrian Hall; Rino A. Bit; Susan H. Brown; Helene M. Chaignot; Iain P. Chessell; Tanya Coleman; Gerard Martin Paul Giblin; David Nigel Hurst; Ian Reginald Kilford; Xiao Qing Lewell; Anton D. Michel; Shiyam Mohamed; Alan Naylor; Riccardo Novelli; Lee Skinner; David J. Spalding; Sac P. Tang; Richard J. Wilson
Bioorganic & Medicinal Chemistry Letters | 2007
Adrian Hall; Susan H. Brown; Iain P. Chessell; Anita Chowdhury; Nicholas Maughan Clayton; Tanya Coleman; Gerard Martin Paul Giblin; Beverley Hammond; Mark P. Healy; Matthew R. Johnson; Ann Metcalf; Anton D. Michel; Alan Naylor; Riccardo Novelli; David J. Spalding; Jennifer Sweeting; Lisa Winyard
Bioorganic & Medicinal Chemistry Letters | 2007
Adrian Hall; Susan H. Brown; Iain P. Chessell; Anita Chowdhury; Nicholas Maughan Clayton; Tanya Coleman; Gerard Martin Paul Giblin; Beverley Hammond; Mark P. Healy; Matthew R. Johnson; Ann Metcalf; Anton D. Michel; Alan Naylor; Riccardo Novelli; David J. Spalding; Jennifer Sweeting
QJM: An International Journal of Medicine | 2005
D. Rh. Thomas; Rachel M. Chalmers; B. Crook; S. Stagg; Hüller Thomas; Glyn Lewis; R. L. Salmon; E.O. Caul; K. L. Morgan; Tanya Coleman; P. Morgan-Capner; M. Sillist; S. M. Kench; D. Meadows; P. Softley